0001144204-18-000667.txt : 20180103
0001144204-18-000667.hdr.sgml : 20180103
20180103212948
ACCESSION NUMBER: 0001144204-18-000667
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180101
FILED AS OF DATE: 20180103
DATE AS OF CHANGE: 20180103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GIRSCHWEILER THOMAS
CENTRAL INDEX KEY: 0001273547
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 18508297
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Taurus4757 GmbH
CENTRAL INDEX KEY: 0001603397
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 18508296
BUSINESS ADDRESS:
STREET 1: WISSMANNSTRASSE 15
CITY: ZURICH
STATE: V8
ZIP: CH 8057
BUSINESS PHONE: 414 43620406
MAIL ADDRESS:
STREET 1: WISSMANNSTRASSE 15
CITY: ZURICH
STATE: V8
ZIP: CH 8057
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
tv482648_4.xml
OWNERSHIP DOCUMENT
X0306
4
2018-01-01
0
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001273547
GIRSCHWEILER THOMAS
C/O BIOLIFE SOLUTIONS, INC.
3303 MONTE VILLA PARKWAY, SUITE 310
BOTHELL
WA
98021
1
0
1
0
0001603397
Taurus4757 GmbH
ROOSSTRASSE 53
CH-8832 WOLLERAU
ZURICH
V8
CH 8057
SWITZERLAND
0
0
1
0
Common Stock
2018-01-01
4
A
0
10000
A
2823843
I
By Taurus
Common Stock
2018-01-03
4
A
0
834
A
2824677
I
By Taurus
The restricted stock was granted to Taurus4757 GmbH ("Taurus"), a wholly owned entity of the reporting person, pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments.
The shares of common stock were issued to Taurus pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of the reporting person receiving $5,000 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter.
/s/ Roderick de Greef, as attorney-in-fact for Thomas Girschweiler and Tauras4757 GmbH
2018-01-03